KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Labcorp Holdings (LH) EPS (Weighted Average and Diluted) (2016 - 2026)

Labcorp Holdings' EPS (Weighted Average and Diluted) history spans 18 years, with the latest figure at $3.35 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 32.94% to $3.35 in Q1 2026 year-over-year; TTM through Mar 2026 was $11.29, a 30.37% increase, with the full-year FY2025 number at $10.46, up 18.33% from a year prior.
  • EPS (Weighted Average and Diluted) hit $3.35 in Q1 2026 for Labcorp Holdings, up from $1.98 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for LH hit a ceiling of $5.23 in Q1 2022 and a floor of -$2.3 in Q4 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged $2.33 across 5 years, with a median of $2.43 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 342.11% in 2023 and later skyrocketed 174.35% in 2024.
  • Tracing LH's EPS (Weighted Average and Diluted) over 5 years: stood at $0.95 in 2022, then crashed by 342.11% to -$2.3 in 2023, then skyrocketed by 174.35% to $1.71 in 2024, then rose by 15.79% to $1.98 in 2025, then surged by 69.19% to $3.35 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for LH at $3.35 in Q1 2026, $1.98 in Q4 2025, and $3.12 in Q3 2025.